Through proteomic profiling of our proprietary compound library, our team identified a selective, fast, and potent molecular glue degrader that induces cereblon degradation via a novel mechanism.

Read the full paper in @natcomms.nature.com: rdcu.be/eQKQk

Learn more about the people, passion and precision shaping the future of targeted protein degradation: bit.ly/4mhJDNf

A big thank you to our fantastic 2025 interns, who include Lauren Brooks, Ramya Naraharisetti, Amit Pandey, Enea Pinchetti, and Mathilde Hemery! We’re grateful for their excellent work and the insights they share here on their experiences at Monte Rosa. #NationalInternDay

This milestone marks meaningful progress in our immunology and inflammation pipeline – and brings us one step closer to potential new treatment options for patients living with serious inflammatory diseases.

Exceptional individuals united as a team are critical to our success. Join us on our epic journey from one of two base camps – Boston and Basel. To view open positions, visit: bit.ly/44yYQmP

Sharon Townson and John Castle comment on our groundbreaking work recently featured on the cover of Science Magazine, @science.org.

We’ve shown the molecular glue target space is broader than previously understood, and we believe we are uniquely positioned to harness its potential: bit.ly/4koxZ1m